Your browser doesn't support javascript.
loading
Key role for myeloid cells: phase II results of anti-G(D2) antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastoma.
Cheung, Nai-Kong V; Cheung, Irene Y; Kramer, Kim; Modak, Shakeel; Kuk, Deborah; Pandit-Taskar, Neeta; Chamberlain, Elizabeth; Ostrovnaya, Irina; Kushner, Brian H.
Affiliation
  • Cheung NK; Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY.
Int J Cancer ; 135(9): 2199-205, 2014 Nov 01.
Article in En | MEDLINE | ID: mdl-24644014

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Neoplasms / Immunoglobulin G / Granulocyte-Macrophage Colony-Stimulating Factor / Drug Resistance, Neoplasm / Myeloid Cells / Antibodies, Monoclonal / Neuroblastoma Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: Int J Cancer Year: 2014 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Neoplasms / Immunoglobulin G / Granulocyte-Macrophage Colony-Stimulating Factor / Drug Resistance, Neoplasm / Myeloid Cells / Antibodies, Monoclonal / Neuroblastoma Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: Int J Cancer Year: 2014 Type: Article